InsiderSignalSign in

← Insider buys

Jeffrey W Sherman bought stock once, on Feb 27, 2026

Director at Larimar Therapeutics, Inc., and 1 other company

SEC CIK 0001230482 · Filings on SEC.gov ↗

$25KBought

$29.5MSold

Mar 2Last buy

Jeffrey W Sherman's record

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Companies

Every filing

12 filings since Feb 2016, newest first

Larimar Therapeutics, Inc.

Director

Horizon Therapeutics Public Ltd Co

EVP and Chief Medical Officer

$762K−3.0%Jan 12

Horizon Therapeutics Public Ltd Co

EVP and Chief Medical Officer

$588K−2.0%Jan 6

Horizon Therapeutics Public Ltd Co

EVP and Chief Medical Officer

$3.2M−16.0%Dec 13

Horizon Therapeutics Public Ltd Co

EVP and Chief Medical Officer

$4.6M−15.0%Apr 8

Horizon Therapeutics Public Ltd Co

EVP and Chief Medical Officer

$5.1M−18.0%Sep 23

Horizon Therapeutics Public Ltd Co

EVP and Chief Medical Officer

$5.7M−23.0%Jul 2

Horizon Therapeutics Public Ltd Co

EVP and Chief Medical Officer

$7.4M−34.0%Dec 9

Horizon Therapeutics Public Ltd Co

EVP and Chief Medical Officer

$523K−3.0%Jul 7

Horizon Therapeutics Public Ltd Co

EVP and Chief Medical Officer

$1.5M−10.0%May 12

Horizon Pharma Plc

EVP and Chief Medical Officer

$58K−2.0%Aug 2

Horizon Pharma Plc

EVP and Chief Medical Officer

$82K−3.0%Feb 29

Filings come from SEC EDGAR. Not investment advice.